Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

BITFORM

Financiado

Cerrado

Multiplexed biosensing and tissue on a chip integrated platform for breast cance...

Multiplexed biosensing and tissue on a chip integrated platform for breast cancer biomarkers monitoring In this project I will develop an integrated multi-module platform in which a breast cancer ecosystem-on-a-chip (BCE-on-a-chip) bioreactor module, connected to an optical biosensing module based on multiplexed Resonant Nanopillars... ver más

02/07/2023

UPM

246K€

Presupuesto del proyecto: 246K€

Líder del proyecto

UNIVERSIDAD POLITÉCNICA DE MADRID No se ha especificado una descripción o un objeto social para esta compañía.

Total investigadores 3947

Fecha límite participación Sin fecha límite de participación.

Ver 3 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2023-07-02

MSCA-IF-2018: Individual Fellowships

I+D

Cerrada hace 6 años

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

3 Participantes

UPM

245.73K€ | Lider

THE REGENTS OF THE UNIVERSIT...

LOS ANGELES UCLA SANTA BARBA...

61.97K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

Biochip-images A Breast Cancer Biomarker Point of CarePOCDiagnostic Platfor... 185K€ Cerrado

PID2020-119087RB-I00 TEST RAPIDOS BASADOS EN NANOMATERIALES PARA DETERMINACION DE... 198K€ Cerrado

DINAMIT Dual Imaging Nano Micro sized Theranostics against cancer 265K€ Cerrado

NanoSCAN Developing multi modality nanomedicines for targeted annotat... 2M€ Cerrado

DI-17-09585 : Body-On-Chip: diseño de sistemas biomiméticos para análisi... 65K€ Cerrado

BARCODE DIAGNOSTICS Next Generation Personalized Diagnostic Nanotechnologies for... 1M€ Cerrado

Duración del proyecto: 51 meses Fecha Inicio: 2019-04-02
Fecha Fin: 2023-07-02

Líder del proyecto

UNIVERSIDAD POLITÉCNICA DE MADRID No se ha especificado una descripción o un objeto social para esta compañía.

Total investigadores 3947

Presupuesto del proyecto 246K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto In this project I will develop an integrated multi-module platform in which a breast cancer ecosystem-on-a-chip (BCE-on-a-chip) bioreactor module, connected to an optical biosensing module based on multiplexed Resonant Nanopillars (R-NPs) transducers, will be developed for biomarkers and anti-breast cancer drug real-time monitoring. Currently attrition rates in clinical trials for new anti-cancer drugs and personalized treatments are higher than all other therapeutic areas. Mainly due to the great reliability on conventional 2D and 3D scaffolds in-vitro culture methodologies in preclinical studies. Those cell-based models are limited by their  inability to conserve the patient tumor features and do not accurately show drug response, observed later in clinical trials. Due to the increasing number of cancer diagnoses, an engineered system that allows an accurate prediction of patient tumor response to anti-cancer drug, is urgently needed. In Bitform Project I will develop a BCE-on-a-chip bioreactor that intends to conserve the cancer tissue characteristics with high reliability. Breast cancer cell secreted biomarkers will be monitored in real-time with a multiplexed biosensing module based on R-NPs. In order to assess the capability of Bitform platform, an anti-cancer drug demonstrator (Paclitaxel) will be tested. By delivering Paclitaxel to the BCE-on-a-chip, monitoring of different cell secreted target biomarkers will permit to evaluate the effect of this drug, and thus to demonstrate the performance of the platform. The Bitform platform will be suitable for different organ-on-chip culture models and biomolecules monitoring secreted by the cells. This will lead to a new methodology for testing anti-cancer therapies on-a-chip. This is a relevant milestone to study the further potential of the Bitform Platform in personalized medicine, which can have a transformative impact not only on the outcome but also on the costs of treatments by avoiding expensive failures.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores